AvaALL: Bevacizumab Beyond Progression in Patients with Metastatic Non-Squamous NSCLC

AvaALL: Bevacizumab Beyond Progression in Patients with Metastatic Non-Squamous NSCLC

User Photo
moasc

3 years
701 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Viola Zhu, MD, PhD of UC Irvine Health discusses the AvaALL trial and the use of bevacizumab beyond progression in patients with non-small cell lung cancer. This was recorded at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beach, CA.

Abstract 90040: AvaALL: Use of Bevacizumab Beyond Progression
Up Next Autoplay
>